[{"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-001", "question": "A 58-year-old man with a history of hypertrophic cardiomyopathy presents with recurrent syncope. Genetic testing reveals a mutation in the MYH7 gene. Echocardiography shows asymmetric septal hypertrophy with a left ventricular outflow tract gradient of 80 mmHg at rest. Despite optimal medical therapy with beta-blockers, he continues to experience symptoms. What is the most appropriate next step in management?", "options": ["Implantable cardioverter-defibrillator placement", "Septal myectomy", "Alcohol septal ablation", "Dual-chamber pacing", "Mavacamten initiation"], "answer": "E", "answer_index": 4, "explanation": "Mavacamten is the most appropriate next step as it is a cardiac myosin inhibitor specifically indicated for symptomatic obstructive hypertrophic cardiomyopathy refractory to beta-blockers, targeting the underlying pathophysiology. Septal myectomy and alcohol septal ablation are invasive options reserved for cases not responding to medical therapy, but mavacamten offers a non-invasive alternative with recent evidence supporting its use before procedural interventions. Implantable cardioverter-defibrillator and dual-chamber pacing address arrhythmic risks but not the outflow obstruction directly.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (multiple answers defensible). The stem describes severe obstructive HCM (80 mmHg gradient) with syncope despite beta-blockade. Standard next step is septal reduction therapy (myectomy or alcohol ablation). Both B and C are guideline-supported invasive options for refractory obstruction; the vignette provides no surgical risk or patient preference to choose between them, making each defensible. Mavacamten (E) is a novel myosin inhibitor approved for symptomatic obstructive HCM, but current guidelines position it as an alternative for patients who are not candidates for or decline invasive therapy, not as the default next step. Thus, the keyed answer (E) is not the unique best choice; the item is miskeyed. Medical accuracy: The rationale overstates mavacamten’s place in the algorithm, misrepresenting standard of care. This is a major inaccuracy (score 2). Logical issue: Underspecification (U) also applies because missing details (surgical candidacy, patient preference) are needed to discriminate between B and C, leading to multiple defensible answers. Minimal fix: Add a sentence stating the patient is a poor surgical candidate due to severe comorbidities, making mavacamten the preferred next step, and update the key to E.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (multiple answers defensible). The stem describes severe obstructive HCM (80 mmHg gradient) with syncope despite beta-blockade. Standard next step is septal reduction therapy (myectomy or alcohol ablation). Both B and C are guideline-supported invasive options for refractory obstruction; the vignette provides no surgical risk or patient preference to choose between them, making each defensible. Mavacamten (E) is a novel myosin inhibitor approved for symptomatic obstructive HCM, but current guidelines position it as an alternative for patients who are not candidates for or decline invasive therapy, not as the default next step. Thus, the keyed answer (E) is not the unique best choice; the item is miskeyed. Medical accuracy: The rationale overstates mavacamten’s place in the algorithm, misrepresenting standard of care. This is a major inaccuracy (score 2). Logical issue: Underspecification (U) also applies because missing details (surgical candidacy, patient preference) are needed to discriminate between B and C, leading to multiple defensible answers. Minimal fix: Add a sentence stating the patient is a poor surgical candidate due to severe comorbidities, making mavacamten the preferred next step, and update the key to E.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-002", "question": "A 72-year-old woman with Parkinson's disease develops sudden onset of severe headache, vomiting, and left-sided hemiparesis. MRI reveals a right thalamic hemorrhage with intraventricular extension. She is on carbidopa-levodopa and has a history of orthostatic hypotension. What is the most likely underlying mechanism contributing to this event?", "options": ["Cerebral amyloid angiopathy", "Hypertensive vasculopathy", "Levodopa-induced vasospasm", "Orthostatic hypotension-related watershed infarction", "Dopaminergic therapy-associated coagulopathy"], "answer": "B", "answer_index": 1, "explanation": "Hypertensive vasculopathy is the most likely mechanism, as chronic hypertension in elderly patients with Parkinson's often leads to small vessel disease and thalamic hemorrhages. Cerebral amyloid angiopathy typically affects cortical regions, not deep structures like the thalamus. Levodopa does not directly cause vasospasm or coagulopathy, and while orthostatic hypotension is common, it more often results in ischemic rather than hemorrhagic events.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. The question is defensible because thalamic (deep) hemorrhage location in a 72-year-old is classic for hypertensive vasculopathy, while cerebral amyloid angiopathy causes lobar bleeds. The 'most likely' framing permits epidemiologic inference without explicit hypertension history. Parkinson's disease and orthostatic hypotension are plausible distractors that don't undermine logic. Each alternative is properly excluded: CAA affects cortical not deep structures (A); levodopa lacks evidence for vasospasm (C) or coagulopathy (E); orthostatic hypotension produces ischemia, not hemorrhage (D). Medical accuracy aligns with standard teaching on ICH etiology. Minor nuance: rationale's link between Parkinson's and hypertensive vasculopathy is indirect, but doesn't compromise correctness. No internal contradictions exist. Minimal fix: Explicitly state 'history of chronic hypertension' in stem for absolute clarity, though current board-style item remains valid.\",\"logical_false_reason\":\"T\",\"logical_validity\":true,\"medical_accuracy_score\":\"4\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. The question is defensible because thalamic (deep) hemorrhage location in a 72-year-old is classic for hypertensive vasculopathy, while cerebral amyloid angiopathy causes lobar bleeds. The 'most likely' framing permits epidemiologic inference without explicit hypertension history. Parkinson's disease and orthostatic hypotension are plausible distractors that don't undermine logic. Each alternative is properly excluded: CAA affects cortical not deep structures (A); levodopa lacks evidence for vasospasm (C) or coagulopathy (E); orthostatic hypotension produces ischemia, not hemorrhage (D). Medical accuracy aligns with standard teaching on ICH etiology. Minor nuance: rationale's link between Parkinson's and hypertensive vasculopathy is indirect, but doesn't compromise correctness. No internal contradictions exist. Minimal fix: Explicitly state 'history of chronic hypertension' in stem for absolute clarity, though current board-style item remains valid.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-003", "question": "A 45-year-old man with type 1 diabetes mellitus presents with recurrent hypoglycemia despite dose adjustments. He has a history of autoimmune thyroiditis and vitiligo. Laboratory evaluation shows low morning cortisol and elevated ACTH. What is the most appropriate confirmatory test for the suspected diagnosis?", "options": ["Cosyntropin stimulation test", "Insulin tolerance test", "21-Hydroxylase antibody assay", "Adrenal CT scan", "Metyrapone test"], "answer": "C", "answer_index": 2, "explanation": "21-Hydroxylase antibody assay is the most appropriate confirmatory test for autoimmune adrenalitis in the context of polyglandular autoimmune syndrome type 2, given the patient's other autoimmune conditions. Cosyntropin stimulation test assesses adrenal reserve but does not confirm etiology. Insulin tolerance and metyrapone tests evaluate the hypothalamic-pituitary-adrenal axis but are less specific for autoimmune causes, and adrenal CT is imaging that may show atrophy but not confirm autoimmunity.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. The stem's autoimmune context (type 1 DM, autoimmune thyroiditis, vitiligo) establishes polyglandular autoimmune syndrome type 2, making autoimmune adrenalitis the suspected etiologic diagnosis. Laboratory values (low morning cortisol, elevated ACTH) confirm primary adrenal insufficiency, but the clinical question asks for confirmation of the *autoimmune* mechanism. 21-hydroxylase antibody assay directly detects the pathogenic autoantibody and is the most appropriate test for confirming autoimmune adrenalitis. Alternative A (cosyntropin stimulation) assesses adrenal reserve but not etiology; B (insulin tolerance) and E (metyrapone) evaluate HPA axis integrity; D (adrenal CT) shows anatomic changes but not immunopathology. The item is medically accurate and consistent with current understanding of autoimmune polyendocrine syndromes. Logical validity is maintained: the heavy autoimmune framing yields a single best answer, though the phrasing requires examinees to recognize that etiologic confirmation is being sought rather than functional assessment.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. The stem's autoimmune context (type 1 DM, autoimmune thyroiditis, vitiligo) establishes polyglandular autoimmune syndrome type 2, making autoimmune adrenalitis the suspected etiologic diagnosis. Laboratory values (low morning cortisol, elevated ACTH) confirm primary adrenal insufficiency, but the clinical question asks for confirmation of the *autoimmune* mechanism. 21-hydroxylase antibody assay directly detects the pathogenic autoantibody and is the most appropriate test for confirming autoimmune adrenalitis. Alternative A (cosyntropin stimulation) assesses adrenal reserve but not etiology; B (insulin tolerance) and E (metyrapone) evaluate HPA axis integrity; D (adrenal CT) shows anatomic changes but not immunopathology. The item is medically accurate and consistent with current understanding of autoimmune polyendocrine syndromes. Logical validity is maintained: the heavy autoimmune framing yields a single best answer, though the phrasing requires examinees to recognize that etiologic confirmation is being sought rather than functional assessment.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-004", "question": "A 60-year-old smoker with COPD presents with progressive dyspnea and hemoptysis. CT chest reveals a 2 cm spiculated nodule in the right upper lobe with mediastinal lymphadenopathy. Bronchoscopy with biopsy confirms squamous cell carcinoma. PET-CT shows no distant metastases. What is the most appropriate initial management?", "options": ["Stereotactic body radiotherapy", "Surgical lobectomy with lymph node dissection", "Concurrent chemoradiotherapy", "Immune checkpoint inhibitor monotherapy", "Epidermal growth factor receptor tyrosine kinase inhibitor"], "answer": "B", "answer_index": 1, "explanation": "Surgical lobectomy with lymph node dissection is the most appropriate for stage I squamous cell lung cancer in a patient with adequate pulmonary reserve, offering the best chance for cure. Stereotactic body radiotherapy is an alternative for non-surgical candidates, but this patient has no contraindications mentioned. Chemoradiotherapy and targeted therapies are for more advanced stages or specific molecular profiles not indicated here.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: M (U leading to M). Verdict: The keyed answer (B) is not uniquely defensible; both surgical lobectomy and concurrent chemoradiotherapy are reasonable depending on the pathologic status of the mediastinal nodes. Key stem clues: 2 cm spiculated nodule (T1b) and presence of mediastinal lymphadenopathy, which raises stage to at least IIIA if malignant. PET-CT excludes distant metastases, but no nodal biopsy is reported, leaving stage ambiguous. If nodes are negative, surgery is best; if positive, concurrent chemoradiotherapy is standard of care. The answer explanation erroneously assumes stage I disease despite the mention of mediastinal lymphadenopathy, a major medical inaccuracy that misleads learners. Logical issue: underspecification of nodal status creates multiple equally plausible answers. Medical accuracy issue: failure to recognize that mediastinal lymphadenopathy in NSCLC typically indicates N2 disease, for which surgery alone is inadequate. Minimal fix: Add ‘EBUS-guided biopsy of mediastinal nodes shows no malignancy’ to confirm stage IA, making B the unambiguous best answer; alternatively, if nodes are positive, change key to C and revise explanation accordingly.\",\n\"medical_accuracy_score\":   \t\t\"2\",\n\"logical_validity\": false,\n\"logical_false_reason\": \"M\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (U leading to M). Verdict: The keyed answer (B) is not uniquely defensible; both surgical lobectomy and concurrent chemoradiotherapy are reasonable depending on the pathologic status of the mediastinal nodes. Key stem clues: 2 cm spiculated nodule (T1b) and presence of mediastinal lymphadenopathy, which raises stage to at least IIIA if malignant. PET-CT excludes distant metastases, but no nodal biopsy is reported, leaving stage ambiguous. If nodes are negative, surgery is best; if positive, concurrent chemoradiotherapy is standard of care. The answer explanation erroneously assumes stage I disease despite the mention of mediastinal lymphadenopathy, a major medical inaccuracy that misleads learners. Logical issue: underspecification of nodal status creates multiple equally plausible answers. Medical accuracy issue: failure to recognize that mediastinal lymphadenopathy in NSCLC typically indicates N2 disease, for which surgery alone is inadequate. Minimal fix: Add ‘EBUS-guided biopsy of mediastinal nodes shows no malignancy’ to confirm stage IA, making B the unambiguous best answer; alternatively, if nodes are positive, change key to C and revise explanation accordingly.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-005", "question": "A 35-year-old woman in the emergency department presents with chest pain, palpitations, and diaphoresis after using cocaine. ECG shows ST-segment elevation in leads V2-V4. Troponin is elevated. Coronary angiography reveals a thrombus in the left anterior descending artery with no underlying atherosclerosis. What is the most appropriate immediate management?", "options": ["Intracoronary thrombolysis", "Percutaneous coronary intervention with stenting", "Systemic anticoagulation with heparin", "Glycoprotein IIb/IIIa inhibitor infusion", "Aspiration thrombectomy"], "answer": "E", "answer_index": 4, "explanation": "Aspiration thrombectomy is the most appropriate for cocaine-induced myocardial infarction due to vasospasm and thrombus without atherosclerosis, allowing removal of the clot while minimizing vessel trauma. Stenting is unnecessary without plaque, and thrombolysis carries bleeding risks. Anticoagulation and glycoprotein inhibitors are adjunctive but not primary interventions for isolated thrombus.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: K (Miskeyed). Verdict: The keyed answer E is incorrect; the unique best answer is B. Key stem clues: STEMI presentation (ST elevation V2-V4, elevated troponin), cocaine-induced vasospasm with thrombus, and absence of atherosclerosis. These findings establish a clear reperfusion indication. Main logical issue: The question conflates aspiration thrombectomy—a non-routine PCI adjunct (ACC/AHA Class III)—with primary reperfusion therapy. While the rationale correctly notes stenting may be unnecessary without plaque, it incorrectly dismisses PCI entirely. Primary PCI (balloon angioplasty ± selective thrombectomy) remains the standard of care for cocaine-related STEMI. Option B represents this standard, whereas E describes an adjunct that cannot standalone as 'immediate management.' The item is also underspecified regarding thrombus burden and residual stenosis, but the primary flaw is miskeying. Medical accuracy: Major error. Current guidelines recommend primary PCI for STEMI; routine aspiration thrombectomy is not indicated and may be harmful. Teaching that thrombectomy alone is 'most appropriate' misrepresents standard practice. Minimal fix: Change key to B and revise rationale to state that primary PCI is indicated, with selective thrombectomy for large thrombus burden, and stenting deferred if the vessel appears normal after vasospasm resolution.\",\"medical_accuracy_score\":   \t\"2\",\"logical_validity\": false,\"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: K (Miskeyed). Verdict: The keyed answer E is incorrect; the unique best answer is B. Key stem clues: STEMI presentation (ST elevation V2-V4, elevated troponin), cocaine-induced vasospasm with thrombus, and absence of atherosclerosis. These findings establish a clear reperfusion indication. Main logical issue: The question conflates aspiration thrombectomy—a non-routine PCI adjunct (ACC/AHA Class III)—with primary reperfusion therapy. While the rationale correctly notes stenting may be unnecessary without plaque, it incorrectly dismisses PCI entirely. Primary PCI (balloon angioplasty ± selective thrombectomy) remains the standard of care for cocaine-related STEMI. Option B represents this standard, whereas E describes an adjunct that cannot standalone as 'immediate management.' The item is also underspecified regarding thrombus burden and residual stenosis, but the primary flaw is miskeying. Medical accuracy: Major error. Current guidelines recommend primary PCI for STEMI; routine aspiration thrombectomy is not indicated and may be harmful. Teaching that thrombectomy alone is 'most appropriate' misrepresents standard practice. Minimal fix: Change key to B and revise rationale to state that primary PCI is indicated, with selective thrombectomy for large thrombus burden, and stenting deferred if the vessel appears normal after vasospasm resolution.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-006", "question": "A 68-year-old man with atrial fibrillation on anticoagulation develops acute right-sided weakness. CT head shows no hemorrhage, and MRI confirms acute ischemic stroke in the left middle cerebral artery territory. He is within 4.5 hours of symptom onset. What is the most critical factor determining eligibility for intravenous thrombolysis?", "options": ["International normalized ratio value", "Time since last anticoagulant dose", "Presence of atrial fibrillation", "Stroke severity on NIHSS scale", "Reversal agent availability"], "answer": "A", "answer_index": 0, "explanation": "The international normalized ratio value is the most critical, as thrombolysis is contraindicated if INR >1.7 in patients on vitamin K antagonists to avoid hemorrhagic complications. Time since last dose affects coagulopathy but INR directly measures it. Atrial fibrillation and stroke severity influence overall management but not thrombolysis eligibility directly, and reversal agents are for bleeding, not pre-thrombolysis.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: U (Underspecified). The stem fails to specify the anticoagulant type, which is essential for determining thrombolysis eligibility. While INR is critical for vitamin K antagonists (contraindicated if >1.7), it is irrelevant for direct oral anticoagulants (DOACs), where time since last dose and reversal agent availability are key considerations. This omission means the question cannot yield a single best answer without unstated assumptions. Verdict: Not uniquely determinable. Key clues: 'on anticoagulation' (type unspecified), within 4.5h window, no hemorrhage. Main logical issue: Missing anticoagulant type creates a scenario where Option A is correct only if warfarin is assumed, but Option B/E could be defensible if DOACs are considered, violating single-best-answer principle. Medical accuracy: The INR threshold is correct for warfarin, but the question's framing is outdated and potentially misleading for modern practice where DOACs predominate. A learner might inappropriately apply INR criteria to a DOAC patient. Minimal fix: Specify 'on warfarin' in the stem to make INR the unambiguous critical factor.\",\"medical_accuracy_score\":   \t\"3\",\"logical_validity\": false,\"logical_false_reason\": \"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: U (Underspecified). The stem fails to specify the anticoagulant type, which is essential for determining thrombolysis eligibility. While INR is critical for vitamin K antagonists (contraindicated if >1.7), it is irrelevant for direct oral anticoagulants (DOACs), where time since last dose and reversal agent availability are key considerations. This omission means the question cannot yield a single best answer without unstated assumptions. Verdict: Not uniquely determinable. Key clues: 'on anticoagulation' (type unspecified), within 4.5h window, no hemorrhage. Main logical issue: Missing anticoagulant type creates a scenario where Option A is correct only if warfarin is assumed, but Option B/E could be defensible if DOACs are considered, violating single-best-answer principle. Medical accuracy: The INR threshold is correct for warfarin, but the question's framing is outdated and potentially misleading for modern practice where DOACs predominate. A learner might inappropriately apply INR criteria to a DOAC patient. Minimal fix: Specify 'on warfarin' in the stem to make INR the unambiguous critical factor.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-007", "question": "A 52-year-old woman with acromegaly undergoes transsphenoidal surgery. Postoperatively, she develops polyuria with urine output exceeding 300 mL/hour. Serum sodium is 148 mEq/L, and urine specific gravity is 1.002. What is the most appropriate initial pharmacologic intervention?", "options": ["Desmopressin acetate", "Hydrochlorothiazide", "Demeclocycline", "Tolvaptan", "Conivaptan"], "answer": "A", "answer_index": 0, "explanation": "Desmopressin acetate is the most appropriate for central diabetes insipidus following pituitary surgery, replacing deficient antidiuretic hormone to concentrate urine. Hydrochlorothiazide is used for nephrogenic diabetes insipidus, not central. Demeclocycline and vasopressin antagonists like tolvaptan or conivaptan are for syndrome of inappropriate antidiuretic hormone, which would worsen hypernatremia here.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. Central diabetes insipidus is definitively established by post-transsphenoidal surgery context combined with polyuria >300 mL/hr, hypernatremia (Na+ 148 mEq/L), and inappropriately dilute urine (specific gravity 1.002). Desmopressin acetate (A) is the unequivocal first-line pharmacologic intervention, replacing deficient ADH. Each distractor is appropriately targeted: hydrochlorothiazide (B) treats nephrogenic DI via a different mechanism; demeclocycline (C), tolvaptan (D), and conivaptan (E) are ADH antagonists indicated for SIADH/hyponatremia and would exacerbate the patient's hypernatremia. The item demonstrates flawless logical structure—single best answer is clear, no internal contradictions exist, and the key is correct. Medical accuracy is gold-standard, fully concordant with current endocrine and neurosurgical guidelines. A trivial enhancement would be adding urine osmolality <100 mOsm/kg for diagnostic precision, but this is unnecessary. No revision required; item is board-examination ready.\",\"medical_accuracy_score\":   \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Central diabetes insipidus is definitively established by post-transsphenoidal surgery context combined with polyuria >300 mL/hr, hypernatremia (Na+ 148 mEq/L), and inappropriately dilute urine (specific gravity 1.002). Desmopressin acetate (A) is the unequivocal first-line pharmacologic intervention, replacing deficient ADH. Each distractor is appropriately targeted: hydrochlorothiazide (B) treats nephrogenic DI via a different mechanism; demeclocycline (C), tolvaptan (D), and conivaptan (E) are ADH antagonists indicated for SIADH/hyponatremia and would exacerbate the patient's hypernatremia. The item demonstrates flawless logical structure—single best answer is clear, no internal contradictions exist, and the key is correct. Medical accuracy is gold-standard, fully concordant with current endocrine and neurosurgical guidelines. A trivial enhancement would be adding urine osmolality <100 mOsm/kg for diagnostic precision, but this is unnecessary. No revision required; item is board-examination ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-008", "question": "A 55-year-old man with idiopathic pulmonary fibrosis presents with acute worsening dyspnea. High-resolution CT shows new ground-glass opacities superimposed on fibrosis. Bronchoalveolar lavage reveals neutrophilia without infection. What is the most appropriate therapeutic approach?", "options": ["High-dose systemic corticosteroids", "Azathioprine addition to regimen", "Pirfenidone dose escalation", "Nintedanib initiation", "Lung transplantation evaluation"], "answer": "A", "answer_index": 0, "explanation": "High-dose systemic corticosteroids are the most appropriate for acute exacerbation of idiopathic pulmonary fibrosis, aiming to suppress inflammation despite limited evidence. Azathioprine is contraindicated due to increased mortality risk. Pirfenidone and nintedanib are antifibrotics for stable disease, not acute flares, and transplantation is for end-stage but not immediate management.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. The vignette captures AE-IPF: acute dyspnea, new ground-glass opacities superimposed on fibrosis, and BAL neutrophilia without infection. High-dose systemic corticosteroids (A) remain the most appropriate immediate therapy—standard clinical practice for AE-IPF, as acknowledged in current guidelines (ATS/ERS/JRS/ALAT 2022) despite limited evidence. Azathioprine (B) is contraindicated due to mortality risk (PANTHER-IPF). Pirfenidone (C) and nintedanib (D) are antifibrotics for stable IPF, not acute exacerbations. Lung transplantation evaluation (E) is a long-term strategy, not emergent management. No internal contradictions; options are distinct and allow clear discrimination. Medical accuracy is solid: the rationale correctly identifies why each distractor is inappropriate. Minor limitation: disease severity (e.g., ICU requirement) is unspecified, but this does not prevent identification of a unique best answer. Minimal fix: Append 'in the absence of contraindications' to the stem to reflect that corticosteroid use is discretionary.\",\"medical_accuracy_score\":   \"4\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. The vignette captures AE-IPF: acute dyspnea, new ground-glass opacities superimposed on fibrosis, and BAL neutrophilia without infection. High-dose systemic corticosteroids (A) remain the most appropriate immediate therapy—standard clinical practice for AE-IPF, as acknowledged in current guidelines (ATS/ERS/JRS/ALAT 2022) despite limited evidence. Azathioprine (B) is contraindicated due to mortality risk (PANTHER-IPF). Pirfenidone (C) and nintedanib (D) are antifibrotics for stable IPF, not acute exacerbations. Lung transplantation evaluation (E) is a long-term strategy, not emergent management. No internal contradictions; options are distinct and allow clear discrimination. Medical accuracy is solid: the rationale correctly identifies why each distractor is inappropriate. Minor limitation: disease severity (e.g., ICU requirement) is unspecified, but this does not prevent identification of a unique best answer. Minimal fix: Append 'in the absence of contraindications' to the stem to reflect that corticosteroid use is discretionary.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-009", "question": "A 28-year-old man in the emergency department after a motor vehicle collision has hypotension, tachycardia, and abdominal distension. FAST exam shows free fluid in the abdomen. He is taken to the operating room for exploratory laparotomy, revealing a splenic laceration. What is the most appropriate intraoperative management for a hemodynamically unstable patient?", "options": ["Splenic artery embolization", "Partial splenectomy", "Splenorrhaphy with hemostatic agents", "Total splenectomy", "Non-operative management with observation"], "answer": "D", "answer_index": 3, "explanation": "Total splenectomy is the most appropriate for hemodynamically unstable patients with high-grade splenic injury to rapidly control bleeding and stabilize the patient. Embolization and non-operative management are for stable patients. Partial splenectomy or splenorrhaphy preserve splenic function but are time-consuming and risky in instability.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. Key stem clues: post-MVC hemodynamic instability (hypotension, tachycardia), abdominal distension, FAST-positive free fluid, exploratory laparotomy confirming splenic laceration, and explicit intraoperative setting. The question asks for the most appropriate management when hemorrhage control is paramount. Total splenectomy (D) is uniquely defensible as the ATLS/EAST guideline-recommended approach for unstable patients with major splenic injury, providing rapid, definitive hemostasis. Alternative exclusion is crisp and stem-based: splenic artery embolization (A) is a non-operative or preoperative adjunct reserved for hemodynamically stable patients; partial splenectomy (B) and splenorrhaphy (C) are splenic-preserving techniques that prolong operative time and increase rebleeding risk in instability; non-operative management (E) is contraindicated in hypotension. No logical flaws: the stem is internally consistent, contains no contradictory details, and the options are mutually exclusive, testing a clear trauma management principle without ambiguity. Medical accuracy is gold-standard: fully aligned with current trauma surgery consensus, uses precise terminology, and the rationale correctly frames decision-making by hemodynamic stability without nuance issues. No safety concerns or outdated guidance. Minimal fix: None required.\",\"medical_accuracy_score\":   \t\"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Key stem clues: post-MVC hemodynamic instability (hypotension, tachycardia), abdominal distension, FAST-positive free fluid, exploratory laparotomy confirming splenic laceration, and explicit intraoperative setting. The question asks for the most appropriate management when hemorrhage control is paramount. Total splenectomy (D) is uniquely defensible as the ATLS/EAST guideline-recommended approach for unstable patients with major splenic injury, providing rapid, definitive hemostasis. Alternative exclusion is crisp and stem-based: splenic artery embolization (A) is a non-operative or preoperative adjunct reserved for hemodynamically stable patients; partial splenectomy (B) and splenorrhaphy (C) are splenic-preserving techniques that prolong operative time and increase rebleeding risk in instability; non-operative management (E) is contraindicated in hypotension. No logical flaws: the stem is internally consistent, contains no contradictory details, and the options are mutually exclusive, testing a clear trauma management principle without ambiguity. Medical accuracy is gold-standard: fully aligned with current trauma surgery consensus, uses precise terminology, and the rationale correctly frames decision-making by hemodynamic stability without nuance issues. No safety concerns or outdated guidance. Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-010", "question": "A 65-year-old woman with rheumatoid arthritis develops shortness of breath. Echocardiography reveals severe mitral regurgitation with a flail leaflet. She has preserved left ventricular function but elevated pulmonary pressures. Coronary angiography is normal. What is the most appropriate intervention?", "options": ["Mitral valve repair", "Mitral valve replacement with bioprosthesis", "Transcatheter edge-to-edge repair", "Medical management with afterload reduction", "Cardiac resynchronization therapy"], "answer": "A", "answer_index": 0, "explanation": "Mitral valve repair is the most appropriate for severe primary mitral regurgitation due to flail leaflet in a surgical candidate, offering better durability and preservation of ventricular function compared to replacement. Transcatheter repair is for high-risk patients or functional regurgitation. Medical management and resynchronization do not address the structural defect.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. The stem presents severe primary mitral regurgitation (MR) due to a flail leaflet in a 65-year-old with preserved LV function and symptomatic dyspnea. Key discriminating clues include: (1) flail leaflet indicating primary/organic MR, (2) preserved LV function suggesting chronic compensated disease, (3) elevated pulmonary pressures confirming hemodynamic impact, and (4) normal coronaries excluding ischemic etiology. Current guidelines (ACC/AHA, ESC) give Class I recommendation for surgical intervention in symptomatic severe primary MR, with valve repair strongly preferred over replacement when anatomically feasible. Repair offers superior durability and LV preservation. The keyed answer A aligns perfectly: this patient is a surgical candidate (age 65, no high-risk features mentioned), making repair the most appropriate intervention. Alternatives are appropriately inferior: replacement (B) is less desirable when repair is feasible; transcatheter edge-to-edge repair (C) is reserved for high-risk or functional MR; medical therapy (D) cannot correct the structural defect; and CRT (E) is for heart failure with reduced EF and electrical dyssynchrony. No contradictions or missing critical details. Medical content is accurate, guideline-concordant, and board-relevant. No fix required.\",\"medical_accuracy_score\":  \t\"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. The stem presents severe primary mitral regurgitation (MR) due to a flail leaflet in a 65-year-old with preserved LV function and symptomatic dyspnea. Key discriminating clues include: (1) flail leaflet indicating primary/organic MR, (2) preserved LV function suggesting chronic compensated disease, (3) elevated pulmonary pressures confirming hemodynamic impact, and (4) normal coronaries excluding ischemic etiology. Current guidelines (ACC/AHA, ESC) give Class I recommendation for surgical intervention in symptomatic severe primary MR, with valve repair strongly preferred over replacement when anatomically feasible. Repair offers superior durability and LV preservation. The keyed answer A aligns perfectly: this patient is a surgical candidate (age 65, no high-risk features mentioned), making repair the most appropriate intervention. Alternatives are appropriately inferior: replacement (B) is less desirable when repair is feasible; transcatheter edge-to-edge repair (C) is reserved for high-risk or functional MR; medical therapy (D) cannot correct the structural defect; and CRT (E) is for heart failure with reduced EF and electrical dyssynchrony. No contradictions or missing critical details. Medical content is accurate, guideline-concordant, and board-relevant. No fix required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]